Concepedia

Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine

Kyp L. Oxley, Brett M. Hanson, Ashley Zani, Gail A. Bishop

Cancer Immunology Immunotherapy · 2021 · 10 citations · 16 references

Open access

Concepts

MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyVaccinologyAntitumor T Cell ResponsesCancer ImmunotherapyCancer VaccinesHumoral ImmunityVaccinationVaccine-based ImmunotherapyB Cell Response To VaccinationCancer Vaccine DevelopmentCancer Vaccine ImmunologyCancer Vaccine ResponsesCancer Vaccine T-cell ResponsesTumor Lysate VaccinesVaccine-induced T-cell Responses

References

16

Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position

Karin Reif, Eric H. Ekland, Lars Ohl et al. · Nature · 2002 · 557 citations

Life Sciences, Cell Biology, Molecular Biology +16

B16 as a Mouse Model for Human Melanoma

Willem W. Overwijk, Nicholas P. Restifo · Current Protocols in Immunology · 2000 · 430 citations · Full text

Life Sciences, Immunology, Oncology +17

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Michael S. von Bergwelt‐Baildon, Robert H. Vonderheide, Britta Maecker et al. · Blood · 2002 · 190 citations

Life Sciences, Cell Biology, Immunology +17

Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte responses

Wolfgang Herr, Elena Ranieri, Walter C. Olson et al. · Blood · 2000 · 153 citations

Life Sciences, Immunology, Infectious Diseases +17

B Cells Are Critical to T-cell—Mediated Antitumor Immunity Induced by a Combined Immune-Stimulatory/Conditionally Cytotoxic Therapy for Glioblastoma

Marianela Candolfi, James F. Curtin, Kader Yagiz et al. · Neoplasia · 2011 · 119 citations · Full text

Medicine, Immunology, Oncology +17